Nantahala Capital Management LLC 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:38 pm Purchase | 2026-06-30 | 13G | FULCRUM THERAPEUTICS INC FULC | Nantahala Capital Management LLC | 5,475,040 8.220% | 2,425,000 (+79.51%) | Filing |
| 2026-05-15 4:36 pm Sale | 2026-03-31 | 13G | FULCRUM THERAPEUTICS INC FULC | Nantahala Capital Management LLC | 3,050,040 4.580% | -1,727,872 (-36.16%) | Filing |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | FULCRUM THERAPEUTICS INC FULC | Nantahala Capital Management LLC | 4,777,912 7.657% | 4,777,912 (New Position) | Filing |